- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 946403, 5 pages
Human Platelet Antigen Genotyping and Expression of CD109 (Human Platelet Antigen 15) mRNA in Various Human Cell Types
1Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul 110-744, Republic of Korea
2Department of Laboratory Medicine, Seoul National University Bundang Hospital, 173-82 Gumiro, Bundanggu, Gyeonggido, Seongnam 463-707, Republic of Korea
Received 12 December 2012; Revised 7 January 2013; Accepted 8 January 2013
Academic Editor: Mina Hur
Copyright © 2013 Sang Mee Hwang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. Lin, D. R. Sutherland, W. Horsfall et al., “Cell surface antigen CD109 is a novel member of the α2 macroglobulin/C3, C4, C5 family of thioester-containing proteins,” Blood, vol. 99, no. 5, pp. 1683–1691, 2002.
- D. R. Sutherland, E. Yeo, A. Ryan, G. B. Mills, D. Bailey, and M. A. Baker, “Identification of a cell-surface antigen associated with activated T lymphoblasts and activated platelets,” Blood, vol. 77, no. 1, pp. 84–93, 1991.
- K. Ertel, M. Al-Tawil, S. Santoso, and H. Kroll, “Relevance of the HPA-15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes,” Transfusion, vol. 45, no. 3, pp. 366–373, 2005.
- A. C. Schuh, N. A. Watkins, Q. Nguyen et al., “A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens,” Blood, vol. 99, no. 5, pp. 1692–1698, 2002.
- Y. Ohshima, I. Yajima, M. Y. Kumasaka et al., “CD109 expression levels in malignant melanoma,” Journal of Dermatological Science, vol. 57, no. 2, pp. 140–142, 2010.
- S. Hagiwara, Y. Murakumo, T. Sato et al., “Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity,” Cancer Science, vol. 99, no. 10, pp. 1916–1923, 2008.
- M. Hashimoto, M. Ichihara, T. Watanabe et al., “Expression of CD109 in human cancer,” Oncogene, vol. 23, no. 20, pp. 3716–3720, 2004.
- A. A. Bizet, K. Liu, N. Tran-Khanh et al., “The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors,” Biochimica et Biophysica Acta, vol. 1813, no. 5, pp. 742–753, 2011.
- P. M. Hernández-Campo, J. Almeida, S. Matarraz, M. de Santiago, M. L. Sánchez, and A. Orfao, “Quantitative analysis of the expression of glycosylphosphatidylinositol-anchored proteins during the maturation of different hematopoietic cell compartments of normal bone marrow,” Cytometry B, vol. 72, no. 1, pp. 34–42, 2006.
- M. Hasegawa, S. Hagiwara, T. Sato et al., “CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells,” Pathology International, vol. 57, no. 5, pp. 245–250, 2007.
- K. W. Finnson, B. Y. Tam, K. Liu et al., “Identification of CD109 as part of the TGF-β receptor system in human keratinocytes,” FASEB Journal, vol. 20, no. 9, pp. 1525–1527, 2006.
- X. Xu, F. Zhu, Y. Ying et al., “Simultaneous genotyping of human platelet antigen-1 to 17w by polymerase chain reaction sequence-based typing,” Vox Sanguinis, vol. 97, no. 4, pp. 330–337, 2009.
- T. D. Schmittgen and K. J. Livak, “Analyzing real-time PCR data by the comparative CT method,” Nature Protocols, vol. 3, no. 6, pp. 1101–1108, 2008.
- C. B. Lozzio and B. B. Lozzio, “Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome,” Blood, vol. 45, no. 3, pp. 321–334, 1975.
- D. H. Seo, S. S. Park, D. W. Kim, K. Furihata, I. Uenof, and K. S. Han, “Gene frequencies of eight human platelet-specific antigens in Koreans,” Transfusion Medicine, vol. 8, no. 2, pp. 129–132, 1998.
- H. O. Kim, Y. Jin, T. S. Kickler, K. Blakemore, O. H. Kwon, and P. F. Bray, “Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations,” Transfusion, vol. 35, no. 2, pp. 863–867, 2003.
- L. J. Murray, E. Bruno, N. Uchida et al., “CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells,” Experimental Hematology, vol. 27, no. 8, pp. 1282–1294, 1999.
- B. Y. Tam and A. Philip, “Transforming growth factor-β receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-β binding proteins,” Journal of Cellular Physiology, vol. 176, no. 3, pp. 553–564, 1998.
- X.-Y. Man, K. W. Finnson, M. Baron, and A. Philip, “CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts,” Arthritis Research and Therapy, vol. 14, no. 3, Article ID R144, 2012.
- A. Haregewoin, K. Solomon, R. C. Hom et al., “Cellular expression of a GPI-linked T cell activation protein,” Cellular Immunology, vol. 156, no. 2, pp. 357–370, 1994.
- C. Brashem-Stein, D. Nugent, and I. D. Bernstein, “Characterization of an antigen expressed on activated human T cells and platelets,” Journal of Immunology, vol. 140, no. 7, pp. 2330–2333, 1988.